

Imagene Fine is a premium cross-linked hyaluronic acid dermal filler designed for refined facial correction, smoothing moderate lines and restoring subtle volume while maintaining a natural-looking finish.
Part of the Imagene dermal filler range, it is formulated using Hy-BRID technology and contains 24mg/ml hyaluronic acid with 0.3% lidocaine to support patient comfort during treatment. Its soft-to-medium gel consistency makes it suitable for practitioners looking for a versatile filler that offers more structure than very light formulations while remaining smooth and highly mouldable. The product is supplied as a 1 × 1ml pre-filled syringe.
Key Benefits
Imagene Fine balances flexibility with controlled volume correction:
Product Details
Key specifications for Imagene Fine:
Always check the physical packaging and current Instructions for Use for exact composition, batch number, expiry date, sterility status and regulatory markings before use.
What Is Imagene Fine?
Imagene Fine is an injectable hyaluronic acid dermal filler developed for facial treatments where controlled volume, smooth tissue integration and natural-looking correction are required. It sits between the lighter and more volumising products within the Imagene range, providing a balance between flexibility and structural support, and is particularly suited to practitioners who require a filler capable of addressing lines, folds and subtle contour enhancement without creating excessive projection.
Hyaluronic Acid, Lidocaine and Hy-BRID Technology
Imagene Fine contains 24mg/ml of cross-linked hyaluronic acid — a substance naturally present within the skin and connective tissues, where it plays an important role in hydration and tissue volume. When injected appropriately, cross-linked HA can provide temporary volume and structural support within the treated area; results are temporary and gradually reduce as the material is naturally broken down by the body.
The gel also contains 0.3% lidocaine (3mg/ml) to help reduce discomfort during injection — practitioners must assess patients for relevant allergies, sensitivities and contraindications before treatment. Imagene Fine is manufactured using Hy-BRID technology, designed to create a stable cross-linked gel with consistent rheological characteristics that contribute to smooth injection, controlled placement and integration within the treated tissue. Its soft-to-medium gel and approximately 400μm particle profile provide controlled volume with a natural appearance, giving more support than a very soft filler while remaining flexible for areas requiring natural movement.
Suitable Treatment Areas
Imagene Fine may be selected by appropriately trained practitioners for a range of facial aesthetic treatments. Potential treatment areas may include:
The exact treatment area and technique must be determined by the treating practitioner based on patient anatomy, clinical assessment and the manufacturer’s Instructions for Use. Treatment outcomes depend on factors including patient anatomy, age, skin quality, treatment area, injection technique, quantity administered, metabolism, lifestyle and previous aesthetic treatments, and results vary between individuals.
Professional Consultation
Before treatment, practitioners should conduct an appropriate consultation and clinical assessment, including consideration of medical history, current medicines, previous aesthetic procedures, known allergies, previous reactions to dermal fillers, lidocaine sensitivity, active infection or inflammation, relevant autoimmune or systemic conditions, pregnancy or breastfeeding status where relevant, patient expectations and suitability of the proposed treatment. Treatment should not proceed where an appropriate contraindication or clinical concern is identified.
Important Vascular Occlusion and Visual Loss Warnings
Dermal filler injection carries a rare but potentially serious risk of accidental intravascular injection or vascular compression. Potential warning signs may include disproportionate or increasing pain, blanching, mottling, dusky or abnormal skin colour, delayed capillary refill, cool skin or progressive tissue changes. Practitioners must be appropriately trained in recognising and managing suspected vascular compromise and should have a current complication-management protocol readily available.
Rare but serious visual complications have also been reported following facial dermal filler injections. Sudden visual disturbance, partial or complete loss of vision, severe eye pain or neurological symptoms during or after treatment must be treated as a medical emergency — stop treatment immediately and activate the appropriate emergency and specialist referral pathway. Imagene Fine must not be intentionally injected into blood vessels, and detailed knowledge of facial anatomy, vascular structures, appropriate injection depth and safe technique is essential.
Potential Treatment Reactions
Temporary local reactions may occur following treatment, including redness, swelling, bruising, tenderness, itching, firmness, injection-site discomfort and temporary asymmetry. These are generally expected to resolve, though duration and severity vary. Less common complications can include infection, inflammatory reactions, nodules, hypersensitivity reactions and vascular compromise. Any unexpected, severe or worsening symptoms should be assessed promptly by an appropriately qualified practitioner.
Sterile Single-Use Product and Aseptic Technique
Imagene Fine is supplied as a sterile pre-filled syringe intended for single use only. Before use, check that the packaging is intact, the syringe is undamaged, the product has not expired, the gel appears suitable and sterility has not been compromised. Do not use if the packaging has been opened or damaged, and do not reuse the syringe or supplied needle. Appropriate aseptic technique must be maintained throughout treatment — prepare the treatment area appropriately, maintain good hand hygiene, use sterile equipment, avoid contaminating sterile components, use an appropriate sterile needle or cannula where permitted, and dispose of sharps immediately following use within an appropriate clinical environment.
Aftercare
Patients should receive appropriate aftercare advice. Depending on the procedure, practitioners may advise temporary avoidance of intense exercise, alcohol, excessive heat, saunas and steam rooms, sunbeds, prolonged UV exposure, massage of the treated area and other facial treatments affecting the injection site. Patients should be given clear instructions on expected reactions and symptoms requiring urgent clinical review.
Storage and Disposal
Store Imagene Fine according to the manufacturer’s stated conditions — in its original packaging until required, protected from excessive heat and freezing, away from direct sunlight where applicable and secure from unauthorised access. Do not use after the expiry date printed on the packaging. Used syringes and needles must be disposed of immediately in an approved sharps container, and unused or contaminated filler material disposed of according to appropriate clinical waste procedures.
Professional Use Only
Imagene Fine is intended for use by appropriately trained and qualified healthcare and aesthetic professionals and must not be self-administered. Purchase of the product does not establish competency to perform injectable aesthetic treatments — practitioners remain responsible for ensuring treatment is clinically appropriate, within their professional scope and competence, and performed in accordance with the manufacturer’s Instructions for Use and current professional guidance.
Compare insurance quotes from trusted partners.
137 products
174 sold